Cheiradone: a vascular endothelial cell growth factor receptor antagonist
<p>Abstract</p> <p>Background</p> <p>Angiogenesis, the growth of new blood vessels from the pre-existing vasculature is associated with physiological (for example wound healing) and pathological conditions (tumour development). Vascular endothelial growth factor (VEGF),...
Main Authors: | Ahmed Nessar, Matou Sabine, Elosta Abdul H, Choudhary Mohammad I, Mesaik Mohammad A, Slevin Mark, Hussain Sajjad, West David, Gaffney John |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-01-01
|
Series: | BMC Cell Biology |
Online Access: | http://www.biomedcentral.com/1471-2121/9/7 |
Similar Items
-
Stilbene glycosides are natural product inhibitors of FGF-2-induced angiogenesis
by: Naz Humera, et al.
Published: (2009-04-01) -
Antiglycation and Antioxidant Properties of Momordica charantia.
by: Ali Aljohi, et al.
Published: (2016-01-01) -
C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression
by: Luque Ana, et al.
Published: (2008-09-01) -
Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration
by: Hussain RM, et al.
Published: (2021-06-01) -
NMDA receptor antagonists in the treatment of patients with vascular cognitive imprairments
by: I.S. Preobrazhenskaya
Published: (2014-10-01)